Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 February 2019 | Story Ruan Bruwer
Tharina van der Walt
The hammer thrower Tharina van der Walt is one of several first-class athletes among the first-year students at Kovsies this year. She is the South African U18 champ and record-holder in 2018.

Several top athletes, some of whom were the very best in the country in their respective events at school, have joined Kovsies as first-year students. They already had their first taste of glory as Kovsies when they recently won their events at the first-year meeting.
 
Among these first-years are Jannes Schlebusch (javelin thrower), Joviale Mbisha (sprinter), Colette Uys (discus/shot-put), and Tharina van der Walt (hammer thrower), who have all represented South Africa in the past two years.
 
Schlebusch won the silver medal at the World U18 championships in 2017, but was injured last year. Great things were expected for 2019, but during the first-year meeting he injured his ankle to such an extent that he will have to undergo an operation that would put him on the sideline for the rest of the season.
 
Van der Walt was the South African schools champ in the hammer throw for girls U19 in 2018, when she managed to set up a new school record of 57,83 m. She was ranked fourth at the World U18 champs in 2017. At the same meeting, Mbisha ended 14th in the 100 m.
 
Uys, who participated in the CAA Southern Region Youth and Junior Championships last year, achieved a second place in the discus at the 2018 National Secondary Schools Championships for girls U19. Other first-years who took part in the SA’s last year, are Vicky Oelofse (1 500 m) and Michael Skosana (long jump).
 
They will strengthen Kovsie Athletics, which already boasts a large group of athletes with international experience. Of the 16 athletes who participated internationally last year, only Kesa Molotsane and Lara Orrock will not be in action for the students again.
 
■ Imperium Residence won the men’s division and Arista/Amelia were the ladies’ winners.
 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept